Premium
Ophthalmic Drug Delivery: Development and Regulatory Considerations
Author(s) -
Novack GD
Publication year - 2009
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2008.297
Subject(s) - clinical pharmacology , drug development , pharmacology , regulatory science , medicine , drug , engineering ethics , engineering , pathology
This review presents an update on the development of ophthalmic drug delivery systems (Table 1), as well as regulatory aspects of product development. This review is based on full papers and published patents as of November 2008. Clinical Pharmacology & Therapeutics (2009); 85 , 5, 539–543 doi: 10.1038/clpt.2008.297